Company Directory

Explore biotech and life sciences companies across the UK.

Cytogenetics
Showing 13 of 3

OGT

Oxford, South East England

Genomic diagnostics products for cytogenetics, oncology and rare disease

Oxford Gene Technology is a genomic diagnostics company developing and manufacturing hybridisation-based reagents and assays for clinical and research laboratories. Its product portfolio spans FISH probes, chromosomal microarrays and next-generation sequencing panels, enabling detection of chromosomal abnormalities and somatic mutations across haematological malignancies, solid tumours, cytogenetics and rare diseases. A FISH probe for KMT2A rearrangement in acute leukaemia received FDA De Novo classification as a companion diagnostic in 2024.

Reagents & Consumables
View profile

ADS Biotec

Glasgow, Scotland

Automated instruments and consumables for cytogenetic and genomic laboratories

ADS Biotec develops and manufactures automated laboratory instruments and consumables for cytogenetic, pathology, and molecular biology applications. Its product range includes robotic systems for chromosome harvesting and spreading, HPLC columns for mRNA purification, and custom buffer and reagent manufacturing services. The company serves research, diagnostic, and clinical laboratories across more than 30 countries. ADS Biotec is a subsidiary of ADSTEC, a Japanese life sciences instrumentation group.

Instruments & EquipmentReagents & Consumables
View profile

Univ8 Genomics

Belfast, Northern Ireland

Integrated NGS assays for genomic profiling of haematological malignancies

Univ8 Genomics is a Belfast-based genomics diagnostics company developing targeted next-generation sequencing assays for the integrated clinical characterisation of haematological malignancies. Its assays enable simultaneous detection of clonal rearrangements, chromosomal translocations, copy number alterations and sequence variants from a single DNA input, replacing multiple parallel testing workflows. Products cover lymphoproliferative and myeloid disorders and have been validated in multicentre international studies across European clinical laboratories.

Biotech
View profile